Skip to main content

Bill Gates says the world would need as many as 14 billion doses of a coronavirus vaccine to stop the virus

* The world could need as many as 14 billion doses of COVID-19 vaccines, Bill Gates said on Thursday in a blog post about the race to develop a way to make people immune to the disease. * "We need to make billions of doses, we need to get them out to every part of the world, and we need all of this to happen as quickly as possible," Gates said. * Gates said he had his eyes on eight to 10 promising candidates, adding that healthcare workers and people in low-income countries should be first in line once we find one that works. * While potential vaccines are progressing with historic speed, they're still months, or even years away, and the biggest challenge lies ahead in proving whether they are safe and effective in humans. * Visit Business Insider's homepage for more stories. Bill Gates believes we may eventually need to produce as many as 14 billion doses of COVID-19 vaccines globally and that we're anywhere from nine months to two years away from making that happen. In a blog post Thursday, the billionaire Microsoft cofounder and philanthropist outlined what the race for a vaccine could look like, including how long it will take to develop one that's both safe and effective, how it will be produced, and who should get it first. "We need to manufacture and distribute at least 7 billion doses of the vaccine," Gates said, adding that number could be "14 billion, if it's a multi-dose vaccine." He said the vaccines should be distributed "as soon as the first batch is ready to go." After healthcare workers, people in low-income countries should be first in line for a vaccine when it's ready since they're more likely to get sick, Gates said. Higher rates of underlying health conditions, poor healthcare systems, and high population densities that make social-distancing measures harder to implement will allow the disease to spread more easily, he said. Gates said there would be massive challenges in developing a safe and effective vaccine, as well as in producing, storing, and distributing them on such a large scale, and that it would require extensive global cooperation. Despite the obstacles, Gates said: "I know it'll get done. There's simply no alternative." "Humankind has never had a more urgent task than creating broad immunity for coronavirus," he said. "We need to make billions of doses, we need to get them out to every part of the world, and we need all of this to happen as quickly as possible. With more than 3.2 million cases and 233,000 deaths globally, scientists have been working with unprecedented speed to develop a vaccine — a process that has typically taken multiple years — but experts say we're still a long ways from being able to widely vaccinate people. Anthony Fauci, the director of the National Institute for Allergies and Infectious Diseases, has similarly said the US is at least 12 to 18 months away from a working vaccine, though experts say an expedited timeline could introduce additional risks. Still, Gates said he was optimistic about a few candidates that are being researched and tested. "As of April 9, there are 115 different COVID-19 vaccine candidates in the development pipeline. I think that eight to ten of those look particularly promising. (Our foundation is going to keep an eye on all the others to see if we missed any that have some positive characteristics, though.)," Gates said. Gates' philanthropic organization, the Bill and Melinda Gates Foundation, has pledged $250 million toward fighting the novel coronavirus, and Gates recently announced that the organization planned to dedicate its full resources to the pandemic. Join the conversation about this story » NOW WATCH: Tax Day is now July 15 — this is what it's like to do your own taxes for the very first time
https://bit.ly/3aWRuue

Popular posts from this blog

Why an early exec quit unicorn food delivery startup Deliveroo to launch a food business in the middle of a pandemic

* A former Deliveroo exec has launched a market food hall startup in the middle of COVID-19. * Dan Warne was managing director of the unicorn startup until 2019, but has now launched Sessions Market as a community food hall concept to rejuvenate UK towns after the pandemic. * Warne says he hopes to bring his experience from Deliveroo, particularly about customer behavior, to the analogue world of food halls. * The first venue, Shelter Hall on Brighton seafront, launches July 4. * Visit Business Insider's homepage for more stories. On Saturday, the UK's bars, restaurants, and cinemas will fling their doors open to customers for the first time since a strict lockdown commenced in late March. Given continued public health concerns around the coronavirus pandemic, it might be unwise to open a new food business right now. But Dan Warne, a former high-level executive at British unicorn startup Deliveroo, has launched Sessions Market, a series of community-orientated food hal...

'What is the X-Ray feature on Amazon Prime Video?': How to find and view bonus material about TV shows and movies

* X-Ray is an exclusive feature on Amazon Prime Video that displays bonus material about a show or movie, similar to the bonus features on a DVD. * X-Ray can show you information about the actors in a scene, the musical soundtrack, trivia, and more. * To activate X-Ray, you generally only need to click or tap within a video that's currently playing.   * Visit Business Insider's Tech Reference library for more stories. Amazon Prime Video's X-Ray feature is, at least for now, not available on any other video streaming service. X-Ray works like the bonus features you find on a DVD or Blu-ray. With just a few clicks or taps, you can get additional information about many of the TV shows and movies on Prime Video. When you activate X-Ray, Prime displays an overlay on top of your show, offering additional information.  Check out the products mentioned in this article: Amazon Prime Video ($8.99 a month at Amazon) Roku (from $49.99 at Roku) There are several kinds of info...

Here are the 9 health-tech startups that got coronavirus stimulus loans to keep workers employed during the pandemic

* The Paycheck Protection Program, created by Congress as part of a $2 trillion coronavirus bailout, helped small businesses stay afloat as they struggled economically during the pandemic.  * Businesses were allowed to qualify for up to $10 million in loans.  * On Monday, the Trump administration released the list of companies that borrowed most of the money. We spotted some applications from health-tech companies among their ranks, many of which are backed by venture capital firms.  * Companies that applied for loans include ZocDoc, HealthTap, Bright.md, and Wildflower Health. * For more stories like this, sign up here for our healthcare newsletter, Dispensed. Health-tech startups were among the recipients of federal loans intended to help small businesses stay afloat during the coronavirus pandemic.  Several of the startups have raised tens of millions from venture capital firms. Still, their business models became strained amid the pandemic, they told Business Insider.  Eve...